In addition, ulcerative colitis patients with colon cancer were found to have significantly lower expression of SAMSN1 compared to those patients without cancer, suggesting that SAMSN1 may inhibit the transition from pre‐neoplastic lesions to overt malignancy in colorectal cancer.24 Here, SAMSN1 is linked to malignant colon neoplasm.